Search

everythinglearnresearchcommunity

for

Search:↓

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

More research is needed to understand and treat frontal fibrosing alopecia.

Early diagnosis and quick treatment improve life quality for FFA patients.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Multiple perifollicular fibromas may actually be unrecognized cases of Birt-Hogg-Dubé syndrome.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

FFA's causes may include environmental triggers and genetic factors.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Fibroblast Growth Factors (FGFs) help maintain and repair skin tissues, which is important for preventing diseases like inflammation, fibrosis, and cancer.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Dermoscopes help tell FPHL apart from other hair loss types and can detect it early by identifying specific patterns.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.